Table 2.
Baseline characteristics of WCD patients stratified by sex.
| Female, n = 129 | Male, n = 579 | p-Value | |
|---|---|---|---|
| Age, mean ± SD | 61.58 ± 17.05 | 60.48 ± 14.04 | 0.441 |
| WCD wear time (h/day), mean ± SD | 21.53 ± 4.41 | 21.09 ± 4.29 | 0.282 |
| WCD wear days, mean ± SD | 56.60 ± 38.98 | 62.86 ± 44.36 | 0.140 |
| WCD shocks, n (%) | 5 (3.8) | 14 (2.4) | 0.082 |
| Appropriate | 5 (3.8) | 11 (1.9) | 0.259 |
| Inappropriate | 0 (0) | 3 (0.5) | 0.259 |
| EF baseline, mean ± SD | 30.17 ± 12.30 | 29.55 ± 11.14 | 0.549 |
| EF follow-up, mean ± SD | 38.18 ± 13.17 | 37.35 ± 12.17 | 0.486 |
| EF improvement > 35%, n (%) | 67 (51.9) | 259 (44.7) | 0.157 |
| Device implantation, n (%) | 41 (31.8) | 203 (35.1) | 0.330 |
| Death during follow-up, n (%) | 10 (7.7) | 32 (5.5) | 0.497 |
| Compliance (> 20 h/day WCD use), n (%) | 109 (84.5) | 446 (77.0) | 0.063 |